Foundation Medicine, Inc., a global precision medicine company, today announced an expansion to its collaboration with Bristol Myers Squibb (NYSE: BMY) to develop FoundationOne(R) CDx as a ...

The metagenomics sequencing market is mainly fueled by the combined influence of several major factors. The growing prevalence of infectious diseases, including emerging and re-emerging pathogens, has ...

Key growth drivers include technological advancements, reduced sequencing costs, and increased interest from academia and pharmaceuticalsDublin, April 20, 2026 (GLOBE NEWSWIRE) -- The "Single Cell ...